Dr Reddys Laboratories (RDY) EBT Margin Growth (3y) (2012 - 2023)
Dr Reddys Laboratories (RDY) EBT Margin Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1,840.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -134.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,626.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,686.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1,570.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 5,487.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -225.00 |
| 10 | Dr Reddys Laboratories | 9.82 Bn | 9.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1,019.00 |
| Mar 31, 2023 | 778.00 |
| Jun 30, 2021 | 674.00 |
| Mar 31, 2021 | 163.00 |
| Sep 30, 2020 | -2,656.00 |
| Sep 30, 2019 | -599.00 |
| Mar 31, 2019 | 87.00 |
| Dec 31, 2018 | -78.00 |
| Sep 30, 2018 | -579.00 |
| Jun 30, 2018 | -756.00 |
| Dec 31, 2017 | -496.00 |
| Sep 30, 2017 | -673.00 |
| Dec 31, 2016 | -1,412.00 |
| Sep 30, 2016 | -552.00 |
| Mar 31, 2016 | 2,145.00 |
| Dec 31, 2015 | -808.00 |
| Sep 30, 2015 | -614.00 |
| Jun 30, 2015 | 62.00 |
| Dec 31, 2014 | -42.00 |
| Sep 30, 2014 | 238.00 |